齐永芬个人简介
E-mail: yongfenqi@163.com
齐永芬，北京大学医学部基础医学院教授，博士研究生导师。目前担任中国病理生理学会动脉粥样硬化专业委员会常务委员、国际动脉粥样硬化学会中国分会理事，中国病理生理学会生物活性小分子专业委员会委员，中国生理学会应激专业委员会委员。主持过国家自然科学基金重大血管研究计划重点项目、以及多项面上项目等。先后以第1完成人获教育部科学技术成果二等奖、华夏医学二等奖、中华医学科技奖三等奖以及北京市科技成果三等奖。在Kidney Int, Cardiovasc Res, ATVB, Basic Res Cardiol, J Mol Med以及J Hypertension等杂志共发表SCI研究论文135 篇, 其中第1和责任作者论文65篇，SCI 论文他引3416次（Web of SCI检索结果），H-index:32。作为副主编或编委参与编写教材多部。
代表性论著：
Zhu Q, Ni XQ , Lu WW, Zhang JS, Ren JL, Wu D , Chen Y , Zhang LS , Yu YR, Tang CS, Qi YF*. Intermedin reduces neointima formation by regulating vascular smooth muscle cell phenotype via cAMP/PKA pathway. Atherosclerosis. 2017;266:212-222.
Lu WW, Jia LX, Ni XQ, Zhao L, Chang JR, Zhang JS, Hou YL, Zhu Y, Guan YF, Yu YR, Du J, Tang CS,Qi YF*.Intermedin1-53 attenuates abdominal aortic aneurysm by inhibiting oxidative stress.Arterioscler Thromb Vasc Biol. 2016;36(11):2176-2190.
Chang JR, Guo J, Wang Y, Hou YL, Lu WW, Zhang JS, , Yu YR, Xu MJ, Liu XY, Wang XJ, Guan YF, Zhu Y, Du J, Tang CS, Qi YF*. Intermedin 1-53 attenuates vascular calcification in rats with chronic kidney disease by upregulation of alpha-Klotho.Kidney Int.2016;89(3):586-600.
Lu WW,Zhao L,Zhang JS,Hou YL,Yu YR,Jia MZ,Tang CS,Qi YF*.Intermedin1-53 protects against cardiac hypertrophy by inhibiting endoplasmic reticulum stress via activating AMP-activated protein kinase. J Hypertens.2015;33(8):1676-87.
Teng X, Song J, Zhang G, Cai Y, Yuan F, Du J, Tang C, Qi Y*. Inhibition of endoplasmic reticulum stress by intermedin(1-53) protects against myocardial injury through a PI3 kinase-Akt signaling pathway.J Mol Med (Berl). 2011; 89(12):1195-1205.
Cai Y, Xu MJ, Teng X, Zhou YB, Chen L, Zhu Y, Wang X, Tang CS, Qi YF*. Intermedin Inhibits Vascular Calcification by Increasing the Level of Matrix {gamma}-carboxyglutamic Acid Protein.Cardiovasc Res. 2010; 85: 864–873